| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 3.1e-05 | 1 |